-
3061
Serum and urine eosinophil-derived neurotoxin (EDN) levels predict biologic response in severe asthma
Published 2025-01-01“…The study protocol is registered at ClinicalTrials.gov (NCT05164939). Results: The findings underscore strong correlations between serum EDN levels, blood eosinophil counts, and treatment responses, with EDN demonstrating comparable predictive capabilities to blood eosinophil counts to determine treatment responses. …”
Get full text
Article -
3062
The Nasal Route as a Potential Pathway for Delivery of Erythropoietin in the Treatment of Acute Ischemic Stroke in Humans
Published 2009-01-01“…However, it will be necessary to initiate clinical trials in stroke patients using intranasal delivery in order to obtain the clinical evidence of its neuroprotectant capacity in the treatment of patients with acute stroke and other neurodegenerative disorders. …”
Get full text
Article -
3063
Early mobilization post-myocardial infarction: A scoping review.
Published 2020-01-01“…More robust evidence from randomized clinical trials is required to inform clinicians and influence practice.…”
Get full text
Article -
3064
Biological Evaluation of Garcinia kola Heckel
Published 2022-01-01“…However, the safety and efficacy of G. kola have not been wholly assessed in humans, and further well-designed clinical trials are needed to corroborate preclinical findings. …”
Get full text
Article -
3065
Prognostic value of circulating Chromogranin A in prostate cancer: a systematic review and meta-analysis
Published 2025-02-01“…Therefore, we conducted a meta-analysis of the available findings to explore the value of circulating Chromogranin A in the prognosis of prostate cancer.MethodsWe systematically searched the PubMed, Embase, Web of Science, Cochrane Library, and Clinical Trials databases for studies on the relationship between CgA and survival outcomes in prostate cancer from inception until December 2024, and we focused on articles detecting circulating CgA, with the primary endpoints of the studies being overall survival (OS), and progression-free survival (PFS).ResultsOf the 2049 articles retrieved, 10 articles met our inclusion criteria, involving a total of 1445 patients. …”
Get full text
Article -
3066
Long Coronavirus Disease Symptoms and their Association with Different Risk Factors
Published 2024-12-01“…So understanding the correlation between appearance of the long COVID-symptoms and these the risk factors presents valuable insights, the conclusions warrant justification through larger clinical trials.…”
Get full text
Article -
3067
A 3-Month, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Ability of an Extra-Strength Marine Protein Supplement to Promote Hair Growth and Decrease Shedding in...
Published 2015-01-01“…This trial is registered with ClinicalTrials.gov Identifier: NCT02297360.…”
Get full text
Article -
3068
Special Problems Associated with Surgical Trials in Inflammatory Bowel Disease
Published 1995-01-01“…However, it also appears that there are certain issues that are unique to, or at least occur more frequently in, clinical trials assessing surgical interventions. The issues of special concern in surgical trials can broadly be categorized as methodological and feasibility issues. …”
Get full text
Article -
3069
The Impact of Polyunsaturated Fatty Acid Supplementation on Inflammatory Markers in Preterm Infants – A Literature Review
Published 2025-01-01“…Materials and Methods A review of randomized clinical trials (RCTs) published in 2020-2024 regarding the relationship between the supplementation of polyunsaturated fatty acids and the levels of inflammatory markers in preterm infants. …”
Get full text
Article -
3070
Thymus and activation-regulated chemokine (CCL17) as a clinical biomarker in atopic dermatitis: significance and limitations in the new treatment era
Published 2025-01-01“…In this new era, TARC remains a useful biomarker for more accurate drug selection and the determination of therapeutic efficacy; Currently, in clinical trials of AD, all outcome measurements depend on the clinical score; however the use of a biomarker, such as TARC, as a secondary outcome measure will clarify the characteristics of each drug and the pathophysiological conditions for which it is expected to be effective.…”
Get full text
Article -
3071
Rimegepant for the treatment of migraine
Published 2022-10-01“…Rimegepant, a second-generation gepant, has shown efficacy in several clinical trials in treating acute migraine. Ongoing trials are also evaluating its role in migraine prophylaxis, and results are promising. …”
Get full text
Article -
3072
Comparative efficacy and safety of co-amoxiclav, cefpodoxime proxetil, and levofloxacin in patients with acute uncomplicated bacterial tonsillitis: A prospective, open-label, paral...
Published 2024-12-01“…Background: No clinical trials have compared the efficacy and safety of beta-lactam antibiotics and fluoroquinolones in acute uncomplicated bacterial tonsillitis. …”
Get full text
Article -
3073
Tibial scoring as a predictor for amputation-free survival in critical limb ischemic patients
Published 2024-12-01“…Creating novel approaches to pinpoint high-risk patients would allow for targeted treatments and support specialized clinical trials focused on limb preservation. This study’s objective is to evaluate tibial adversity and scoring for risk of lower extremity amputation in critical limb ischemic patients (CLI). …”
Get full text
Article -
3074
A scoping review protocol on diagnostic strategies to detect occult malignancies in individuals with ischemic stroke.
Published 2023-01-01“…Addressing this knowledge gap will help guide the development of future clinical trials on occult cancer screening patients with ischemic stroke.…”
Get full text
Article -
3075
Dry Swab-Based Nucleic Acid Extraction vs. Spin Column-Based Nucleic Acid Extraction for COVID-19 RT-PCR Testing: A Comparative Study
Published 2023-01-01“…The trial was registered with the Clinical Trials Registry of India (CTRI) with a CTRI registration number of CTRI/2021/12/038792.…”
Get full text
Article -
3076
Musculoskeletal Adverse Events Associated with PCSK9 Inhibitors: Disproportionality Analysis of the FDA Adverse Event Reporting System
Published 2022-01-01“…Some studies suggest that potential safety issues about PCSK9 inhibitors have not been sufficiently explored in clinical trials, including musculoskeletal adverse events (MAEs). …”
Get full text
Article -
3077
Pembrolizumab for the Treatment of Locally Advanced Cutaneous Squamous Cell Carcinoma: Patient Selection and Special Considerations
Published 2025-02-01“…Pembrolizumab, approved by the FDA in 2020 for recurrent or metastatic cSCC not amenable to curative surgery or radiation, has shown promising results in clinical trials. Immunotherapy is also being explored in neoadjuvant settings, with ongoing trials evaluating its potential to improve outcomes for high-risk patients with recurrent or metastatic disease. …”
Get full text
Article -
3078
Is there a risk of esketamine misuse in clinical practice?
Published 2025-01-01“…In 2019, intranasal esketamine gained approval as a promising therapy for those individuals grappling with treatment-resistant depression. Both clinical trials and real-world studies have underscored its efficacy in alleviating and remitting depressive symptoms, with sustained benefits observed for nearly 4.5 years. …”
Get full text
Article -
3079
Analysis of restoration in atrophic scar by intradermal autologous dermal tissue: a pilot study
Published 2025-01-01“…It is important to continue conducting research and clinical trials to establish the benefits and limitations of autologous dermal tissue transplantation for depressed scars. …”
Get full text
Article -
3080
Minimally invasive lateral, posterior, and posterolateral sacroiliac joint fusion for low back pain: a systematic review and meta-analysis
Published 2025-02-01“…Methods The PubMed, Web of Science, Embase, Cochrane Library, and ClinicalTrials.gov databases were comprehensively searched for studies up to 31 August 2024. …”
Get full text
Article